Stone House Investment Management »

Kalvista Pharmaceuticals shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $226 14 16.14

More positions owned by Stone House Investment Management

Spdr Series Trust State Street Spd (SPYM)
Ishares Tr Core Univrsl Usd (IUSB)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr S&p 500 Val Etf (IVE)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Core Msci Emkt (IEMG)
Procter & Gamble Company (PG)
Ishares Tr S&p 100 Etf (OEF)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Ishares Us Thema (THRO)

View all positions for Stone House Investment Management

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Tang Capital Management
BlackRock
Capital World Investors
Vanguard Group
Silverarc Capital Management
Point72 Asset Management
Millennium Management
Woodline Partners
State Street Corporation
Vestal Point Capital
Kynam Capital Management
Parkman Healthcare Partners

View all funds holding Kalvista Pharmaceuticals